Today, with co-authors Pamela M. Ling and Jesse Elias, our paper “The Pharmaceuticalization of the Tobacco Industry” appears in the Annals of Internal Medicine.
Our interview with Reuters is available here.
This work contributes to the study of industrial epidemics, and how corporations, instead of dying a quiet death as the world wakes up to the inutility of their products for life, metastasize into other structures to clean up the messes they continue to create–and to charge taxpayers for it (in this case, by getting government health care like the NHS in the UK, to pay for their so-called reduced-harm nicotine products).